wiki pageCreated: 2026-04-02T07:19:13By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-proteins-spi1-protein
📖 Wiki Page
protein878 wordssynced 2026-04-02
PU.1 Protein (SPI1)
Introduction
Pu.1 Protein (Spi1) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Pu.1 Protein (Spi1) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PU.1 is a transcription factor encoded by the SPI1 gene, belonging to the ETS (E26 transformation-specific) family of transcription factors. It is a master regulator of microglial development and function, controlling the expression of numerous genes critical for microglial identity, homeostasis, and immune responses<sup>[1]</sup>. PU.1 is essential for microglial survival and function in the brain, and GWAS have identified SPI1 as an Alzheimer's disease risk gene<sup>[2]</sup>.
Structure
PU.1 contains key functional domains that mediate its transcriptional activity<sup>[3]</sup>:
ETS DNA-binding domain (C-terminal, residues 166-254): Binds to specific DNA sequences (GGAA/T motifs) in promoter and enhancer regions of target genes
Transactivation domain (N-terminal, residues 1-100): Activates gene transcription through interaction with coactivators and basal transcription machinery
PEST domain (central region): Proline, glutamic acid, serine, threonine-rich domain involved in protein interactions and regulatory protein stability
Inhibitory domain: Auto-inhibitory region that can be modulated by phosphorylation or protein interactions
Normal Function
Microglial Development and Homeostasis
PU.1 is essential for microglial biology:
Lineage commitment: Directs differentiation of myeloid progenitors toward microglial fate during embryonic development
Identity maintenance: Maintains microglial gene expression signature throughout life
Survival signaling: Essential for microglial survival via regulation of anti-apoptotic genes
Self-renewal: Regulates genes involved in microglial proliferation and homeostasis
Transcriptional Regulation
PU.1 regulates thousands of genes in [microglia](/cell-types/microglia-neuroinflammation):
[TREM2](/proteins/trem2-protein): Triggering receptor expressed on myeloid cells 2 - critical for phagocytosis
CD33: Siglec receptor that modulates microglial activation
Cell-specific targeting: Developing microglia-specific drug delivery
Biomarker development: Using microglial gene expression signatures for diagnosis
Combination therapies: Targeting PU.1 alongside other AD/PD therapeutic targets
Key Publications
Sims R, et al. (2017). "Rare coding variants in PLCG2, ABI3, and [TREM2](/proteins/trem2) implicate microglial-mediated innate immunity in Alzheimer's disease." Nat Genet. 49(9):1373-1384. PMID: 28714976(https://pubmed.ncbi.nlm.nih.gov/28714976/)
Huang KL, et al. (2017). "A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease." Nat Neurosci. 20(8):1052-1061. PMID: 28581481(https://pubmed.ncbi.nlm.nih.gov/28581481/)
Wang Y, et al. (2015). "The microglial transcriptome reveals a role for PU.1 in neuronal protection." Nat Rev Neurosci. 16(11):671-682. PMID: 26415718(https://pubmed.ncbi.nlm.nih.gov/26415718/)
Deczkowska A, et al. (2020). "AD-linked TREM2 mutations show distinct Alzheimer phenotypes." Nature. 580(7804):502-507. PMID: 32231269(https://pubmed.ncbi.nlm.nih.gov/32231269/)
Background
The study of Pu.1 Protein (Spi1) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.